The 5 Phenotypes of Tricuspid Regurgitation
JACC: Cardiovascular Interventions · 2023-01 · 16 (2) · 156-165
DOI: 10.1016/j.jcin.2022.10.055 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Cardiovascular Interventions, 2023-01. Verfasst von Vidhu Anand und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: anand.vidhu@mayo.edu. Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Atrial Fibrillation. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: The recent morphologic classification of tricuspid regurgitation (TR) (ie, atrial functional, ventricular functional, lead related, and primary) does not capture underlying comorbidities and clinical characteristics. OBJECTIVES: This study aimed to identify the different phenotypes of TR using unsupervised cluster analysis and to determine whether differences in clinical outcomes were associated with these phenotypes. METHODS: We included 13,611 patients with ≥moderate TR from January 2004 to April 2019 in the final analyses. Baseline demographic, clinical, and echocardiographic data were obtained from electronic medical records and echocardiography reports. Ward's minimum variance method was used to cluster patients based on 38 variables. The analysis of all-cause mortality was performed using the Kaplan-Meier method, and groups were compared using log-rank test. RESULTS: The mean age of patients was 72 ± 13 years, and 56% were women. Cluster analysis identified 5 distinct phenotypes: cluster 1 represented "low-risk TR" with less severe TR, a lower prevalence of right ventricular enlargement, atrial fibrillation, and comorbidities; cluster 2 represented "high-risk TR"; and clusters 3, 4, and 5 represented TR associated with lung disease, coronary artery disease, and chronic kidney disease, respectively. Cluster 1 had the lowest mortality followed by clusters 2 (HR: 2.22 [95% CI: 2.1-2.35]; P < 0.0001) and 4 (HR: 2.19 [95% CI: 2.04-2.35]; P < 0.0001); cluster 3 (HR: 2.45 [95% CI: 2.27-2.65]; P < 0.0001); and, lastly, cluster 5 (HR: 3.48 [95% CI: 3.07-3.95]; P < 0.0001). CONCLUSIONS: Cluster analysis identified 5 distinct novel subgroups of TR with differences in all-cause mortality. This phenotype-based classification improves our understanding of the interaction of comorbidities with this complex valve lesion and can inform clinical decision making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: anand.vidhu@mayo.edu.
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA; Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
Zitieren
APA
Anand, V., Scott, C. G., Hyun, M. C., Lara-Breitinger, K., Nkomo, V. T., Kane, G. C., Pislaru, C., Kopecky, K. F., Schulte, P. J., & Pislaru, S. V. (2023). The 5 Phenotypes of Tricuspid Regurgitation. JACC: Cardiovascular Interventions, 16(2), 156-165. https://doi.org/10.1016/j.jcin.2022.10.055
Vancouver
Anand V, Scott CG, Hyun MC, Lara-Breitinger K, Nkomo VT, Kane GC, et al. The 5 Phenotypes of Tricuspid Regurgitation. JACC: Cardiovascular Interventions. 2023;16(2):156-165. doi:10.1016/j.jcin.2022.10.055
BibTeX
@article{Anand2023,
author = {Anand, Vidhu and Scott, Christopher G and Hyun, Meredith C and Lara-Breitinger, Kyla and Nkomo, Vuyisile T and Kane, Garvan C and Pislaru, Cristina and Kopecky, Kathleen F and Schulte, Phillip J and Pislaru, Sorin V},
title = {The 5 Phenotypes of Tricuspid Regurgitation},
journal = {JACC: Cardiovascular Interventions},
year = {2023},
volume = {16},
number = {2},
pages = {156--165},
doi = {10.1016/j.jcin.2022.10.055}
}
EUVIMED